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Background: Increasing evidence supports an association between age-related loss of muscle mass and insulin resistance. How-
ever, the association has not been fully investigated in the general population. Thus, we investigated the association between ap-
pendicular skeletal muscle mass (ASM) and insulin resistance in an elderly Korean population. 
Methods: This cross-sectional study included 158 men (mean age, 71.8) and 241 women (mean age, 70.6) from the Korean So-
cial Life, Health and Aging Project, which started in 2011. In this study, ASM was measured by bioelectrical impedance analysis 
and was analyzed in three forms: ASM (kg), ASM/height2 (kg/m2), and ASM/weight (%). The homeostasis model assessment of 
insulin resistance (HOMA-IR) was used as a measure of insulin resistance. The relationships between the ASM values and the 
HOMA-IR were investigated by multiple linear regression models. 
Results: The HOMA-IR was positively associated with ASM (β=0.43, P<0.0001) and ASM/height2 (β=0.36, P<0.0001) when 
adjusted for sex and age. However, after additional adjustment for body weight, HOMA-IR was inversely associated with ASM 
(β=–0.43, P<0.001) and ASM/height2 (β=–0.30, P=0.001). Adjustment for other potential confounders did not change these 
associations. Conversely, HOMA-IR was consistently and inversely associated with ASM/weight before and after adjustment for 
other potential confounders. 
Conclusion: Our results support the idea that lower skeletal muscle mass is independently associated with insulin resistance in 
older adults. When evaluating sarcopenia or muscle-related conditions in older adults, their whole body sizes also need to be 
considered.
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INTRODUCTION
Sarcopenia, the decline of muscle mass and strength with age 
[1], is a fundamental cause of functional decline, disability, and 
frailty in older persons [2-5]. Sarcopenia is characterized by a 
decrease in the total number of skeletal muscle fibers, reduced 
thigh circumference, and increased intramuscular fat content 
[6,7] Although the specific mechanism has not been fully iden-
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tified, primary causes of sarcopenia are known to be related to 
aging, undernutrition, sedentary lifestyle, inflammation [8-10], 
oxidative stress [11], and decreased testosterone [12]. Sarcope-
nia can contribute to the development of insulin resistance and 
type 2 diabetes because skeletal muscle is the primary site of in-
sulin-stimulated glucose disposal at euglycemia [13-17]. Insu-
lin resistance, an attenuated ability of insulin to generate its 
physiological responses, is associated with various age-related 
problems, including atherothrombotic vascular diseases, cer-
tain types of cancers, frailty, and cognitive decline.
 Although increasing evidence supports an association be-
tween sarcopenia and insulin resistance, the effects of declin-
ing skeletal muscle mass on insulin resistance have not been 
fully investigated in the general population. Thus, we investi-
gated the relationship between appendicular skeletal muscle 
mass (ASM) and insulin resistance among community-dwell-
ing elderly Koreans without a history of diabetes and cardio-
vascular disease. 
METHODS
Study population
The Korean Social Life, Health and Aging Project (KSHAP), 
which was started in 2011, recruited people aged 60 years or 
older and their spouses living in the rural township (myeon) 
of Ganghwa-gun, Incheon, South Korea. A total of 814 out of 
860 eligible people in the community agreed to participate in 
the study and completed the questionnaire survey. The KS-
HAP-Health Examination Cohort was consisted of 698 people 
who completed additional health examinations at a public 
health center (n=533) or at home (n=165). Body composition 
analysis was available only at the public health center exami-
nation. Among the 533 participants, people with a known past 
history of cardiovascular disease (coronary heart disease and 
stroke), under treatment for diabetes, or missing important 
covariate data were excluded. Ultimately, 399 participants (158 
men and 241 women) were included in the current study. The 
Institutional Review Board of Yonsei University approved the 
study protocol (YUIRB-2011-012-01), and all participants pro-
vided written informed consent.
Measurements
Information about age, smoking status (never or ever smoker), 
and alcohol intake (non-drinker or drinker) was obtained us-
ing a questionnaire survey. Standing height was measured to 
the nearest 0.1 cm using a stadiometer, and body weight was 
measured to the nearest 0.1 kg on a digital scale up according 
to the predetermined manual. Body mass index (BMI) was cal-
culated as an individual’s body weight in kilograms divided by 
their height in meters squared. Physical function was assessed 
by a 3-m timed up and go (TUG) test. The TUG measures the 
time required for the participants to rise from a chair, walk 3 m 
to the end of a line (pre-arranged) and then return to the chair 
and sit down. Resting systolic and diastolic blood pressures 
were measured at least twice using an oscilloscopic automatic 
sphygmomanometer (Dinamap 1846 SX/P; GE Healthcare, 
Waukesha, WI, USA). Prior to each measurement, all partici-
pants had rested for at least 5 minutes in a seated position, and 
the cuff size was adapted to their right upper arm circumfer-
ence. If the first and second measurements differed by ≥10 mm 
Hg, additional measurements were performed, and the average 
of the last two measurements was included in this analysis. 
 Each participant’s ASM was measured by the bioelectrical 
impedance analysis method (Inbody370; Biospace, Seoul, Ko-
rea), according to the instructions provided by the manufac-
turer. The participants stood up straight and comfortably on 
the analyzer’s footplate while barefoot, with legs apart and 
arms. This analyzer measures segmental impedances at the 
right arm, left arm, right leg, left leg, and trunk using a multi-
frequency of 5, 50, and 250 kHz. In this study, ASM was esti-
mated by the sum of muscle mass estimated individually for 
two arms and two legs. Three muscle values including ASM 
(kg), ASM/height2 (kg/m2), and ASM/weight (%) were used 
for statistical analysis. Insulin and glucose levels were mea-
sured from fasting (at least 8 hours) blood samples. Insulin 
level was determined by radioimmunoassay, and the fasting 
blood glucose level was measured using the colorimetry meth-
od. To evaluate insulin resistance, we used the homeostasis 
model assessment of insulin resistance (HOMA-IR) according 
to the following formula: HOMA-IR=fasting plasma glucose 
(mg/dL)×fasting insulin (μIU/mL)/405 [18].
Statistical analyses
Gender differences were analyzed using the independent t-test 
for continuous variables and the chi-square test for categorical 
variables. Fasting insulin levels were log-transformed for para-
metric testing due to the distribution that was skewed to the 
right. The relationship between ASM and HOMA-IR was eval-
uated using Pearson correlation analysis and is presented with 
scatter plots. To examine the independent associations of the 
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three forms of ASM with HOMA-IR, we applied serial multi-
ple linear regression models: model 1 included sex and age; 
model 2 included sex, age and weight; and model 3 included 
sex, age, weight, height, systolic blood pressure, total choles-
terol, high density lipoprotein cholesterol, triglyceride, C-re-
active protein, smoking, and alcohol intake. To assess the ro-
bustness of our findings, we repeated the analysis without ex-
cluding people with a past history of cardiovascular disease. 
We also performed additional analyses to compare those who 
underwent body composition analysis and those who did not. 
All analyses were performed using SAS statistical version 9.2 
(SAS Institute Inc., Cary, NC, USA). All statistical tests were 
two-sided and P values less than 0.05 were considered statisti-
cally significant.
RESULTS
The general characteristics of the study population are pre-
sented in Table 1. Men had lower BMI but greater ASM and 
wider thigh circumference than women. Fasting glucose was 
higher in men, but fasting insulin levels and HOMA-IR values 
were higher in women.
 A previous Korean study analyzing adults aged 60 years or 
older in the Fourth Korean National Health and Nutritional 
Examination Surveys suggested cutoff points of ASM/weight 
determining sarcopenia as 29.5% in men and 23.2% in women 
[19]. In our study, the mean ASM/weight was 31.2% in men 
and 25.2% in women. Another previous Korean study of older 
adults (60 years or older) suggested cutoff points of ASM/
height2 determining sarcopenia as 7.4 kg/m2 in men and 5.1 
kg/m2 in women [20]. The Asian Working Group for Sarcope-
nia, by using bioimpedance analysis, suggested cutoff points of 
7.0 kg/m2 in men and 5.7 kg/m2 in women [21]. In our study, 
the mean ASM/height2 was 7.2 kg/m2 in men and 6.1 kg/m2 in 
women.
 Table 2 presents the correlations between muscle values and 
Table 1. The general characteristics of the study population
Variable Total (n=339) Men (n=158) Women (n=241) P value
Age, yr 71.0±7.7 71.8±7.3 70.6±7.8 0.125
Height, cm 155.5±8.9 163.3±6.2 150.4±6.4 <0.001
Weight, kg 58.1±10.3 62.4±10.0 55.3±9.5 <0.001
Body mass index, kg/m2 24.0±3.4 23.4±3.5 24.3±3.3 0.005
ASM, kg 16.1±3.8 19.4±2.9 13.9±2.5 <0.001
ASM/weight, % 27.6±4.1 31.2±3.2 25.2±2.7 <0.001
ASM/height2, kg/m2 6.5±0.9 7.2±0.8 6.1±0.7 <0.001
Thigh circumference, cm 47.6±3.8 48.6±3.7 47.0±3.7 <0.001
Systolic blood pressure, mm Hg 131.9±18.4 132.0±19.2 131.8±17.9 0.888
Diastolic blood pressure, mm Hg 71.4±9.8 73.5±10.0 70.1±9.4 0.001
3-m timed up and go test, sec 12.7±3.4 12.1±3.4 13.0±3.3 0.010
Total cholesterol, mg/dL 187.7±33.6 177.9±32.4 194.2±32.9 <0.001
HDL-C, mg/dL 53.0±12.7 52.9±12.7 53.2±12.8 0.818
Triglyceride, mg/dL 151.8±76.7 149.9±83.3 153.1±72.1 0.691
C-reactive protein, mg/L 2.5±7.6 3.7±11.0 1.7±4.0 0.028
Fasting glucose, mg/dL 89.9±11.5 92.1±14.1 88.5±9.2 0.004
Insulin, mg/dL 6.8 (5.5–8.7) 6.4 (4.9–8.0) 7.3 (5.8–9.2) <0.001
HOMA-IR 1.7±0.9 1.6±0.9 1.8±0.9 0.040
Smoking, ever (n=388) 102 (30.1) 98 (64.5) 4 (1.7) <0.001
Alcohol intake, ever (n=388) 134 (39.5) 90 (59.2) 44 (18.6) <0.001
Values are presented as mean±standard deviation, median (interquartile range), or number (%). 
ASM, appendicular skeletal muscle mass; HDL-C, high density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin 
resistance.
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Fig. 1. Correlation between appendicular skeletal muscle mass (ASM) and homeostasis model assessment of insulin resistance 
(HOMA-IR). (A) ASM and HOMA-IR in 158 men (Pearson coefficient=0.281, P=0.0004). (B) ASM and HOMA-IR in 241 
women (Pearson coefficient=0.250, P<0.0001). (C) ASM/height2 and HOMA-IR in 158 men (Pearson coefficients=0.287, 
P=0.0003). (D) ASM/height2 and HOMA-IR in 241 women (Pearson coefficient=0.255, P<0.0001). (E) ASM/weight and 
HOMA-R in 158 men (Pearson coefficient=–0.431, P<0.0001). (F) ASM/weight and HOMA-IR in 241 women (Pearson coeffi-
cient=–0.253, P<0.0001).
Table 3. Multiple linear regression coefficients of ASM with homeostasis model assessment of insulin resistance
Variable
ASM ASM/height2 ASM/weight
Standardized 
coefficient
Adjusted 
R2 P value
Standardized 
coefficient
Adjusted
R2 P value
Standardized 
coefficient
Adjusted
R2 P value
Total (n=339)
   Model 1  0.43 0.08 <0.001   0.36 0.08 <0.001 –0.50 0.13 <0.001
   Model 2 –0.43 0.27 <0.001 –0.32 0.29 <0.001 –0.26 0.27 <0.001
   Model 3 –0.50 0.29 0.001 –0.33 0.29 <0.001 –0.30 0.29 0.001
Men (n=158)
   Model 1  0.30 0.07 0.001   0.30 0.07 0.001 –0.45 0.20 <0.001
   Model 2 –0.40 0.36 <0.001 –0.40 0.36 <0.001 –0.25 0.35 0.001
   Model 3 –0.61 0.40 <0.001 –0.46 0.41 <0.001 –0.36 0.39 0.001
Women (n=241)
   Model 1  0.33 0.07 <0.001   0.29 0.06 <0.001 –0.27 0.07 <0.001
   Model 2 –0.24 0.20 0.036 –0.15 0.19 0.112 –0.13 0.20 0.032
   Model 3 –0.19 0.23 0.195 –0.14 0.23 0.161 –0.12 0.23 0.143
Model 1: adjusted for sex, age. Model 2: adjusted for sex, age, weight. Model 3: adjusted for sex, age, weight, height, smoking, alcohol intake, 
systolic blood pressure, triglyceride, total cholesterol, high density lipoprotein cholesterol, and C-reactive protein.
ASM, appendicular skeletal muscle mass.
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other variables using the Pearson correlation coefficients with 
and without adjustment for age. ASM and ASM/height2 were 
significantly and positively correlated with HOMA-IR before 
and after adjusting for age in both men and women. However, 
ASM/weight had a significant inverse correlation with HOMA-
IR before and after adjusting for age. The relationships between 
muscle values and HOMA-IR were also presented using scatter 
plots, separately for men and women (Fig. 1).
 Table 3 shows the relationships between ASM and HOMA-
IR in multiple linear regression analyses. HOMA-IR was posi-
tively associated with ASM (β=0.43, P<0.0001) and ASM/
height2 (β=0.36, P<0.0001) when adjusted for sex and age. 
However, after additional adjustment for body weight, HOMA-
IR was inversely associated with ASM (β=–0.47, P=0.001) and 
ASM/height2 (β=–0.32, P=0.001). These inverse associations 
were not affected by additional adjustment for height, blood 
pressure, mobility function, C-reactive protein, lipid profiles, 
smoking, and alcohol intake. Conversely, HOMA-IR was sig-
nificantly and inversely associated with ASM/weight before 
and after adjustment for sex and age. Additional adjustment for 
other potential confounders did not change this association. 
When analyses were performed for men and women separate-
ly, the inverse associations between ASM and HOMA-IR were 
more prominent in men than in women.
 Because only a portion (63.1%) of the KSHAP participants 
had their body composition measured with bioimpedance 
methods, we compared those who underwent body composi-
tion analysis and those who did not. There was no significant 
difference in the health behaviors and known chronic diseases 
between the two groups. The only exception was hypertension; 
the prevalence of known hypertension was 53.1% in those who 
underwent body composition measurement and 43.3% in 
those who did not (P=0.01). The results of sensitivity analyses 
including people with a past history of cardiovascular disease 
were very similar to the former results excluding people with a 
past history of cardiovascular disease (data not shown).
DISCUSSION
We examined the relationship between ASM and HOMA-IR 
in an elderly Korean population. After adjusting for potential 
confounders, HOMA-IR was significantly and inversely asso-
ciated with ASM, particularly in men. Our finding reaffirms 
the association between age-related muscle loss and insulin 
resistance. 
 Two cross-sectional analyses using the U.S. National Health 
and Nutrition Examination Survey III data reported that higher 
muscle mass is associated with lower insulin resistance and low-
er risk of diabetes, independent of obesity [16,22]. A previous 
Korean study with 4,558 males and 5,874 females aged 20 years 
or older also reported a significant association between insulin 
resistance and sarcopenia [23]. The study suggested that sarco-
penia may be an early predictor for diabetes and metabolic syn-
drome in the nonobese population, particularly in the elderly. 
Another Korean study including 493 apparently healthy adults 
(180 men and 313 women) reported that HOMA-IR levels were 
negatively associated with relative muscle mass (total skeletal 
muscle mass divided by body weight) [24]. A recent cohort 
study of apparently healthy older men reported that insulin re-
sistance was associated with lower relative ASM after 4.6-years 
of follow-up [25]. Conversely, one study reported that skeletal 
muscle mass is not related to glucose tolerance or insulin sensi-
tivity in overweight and obese men and women independent of 
age and total adiposity [26]. 
 An elderly cohort study in Korea reported that HOMA-IR 
was positively correlated with ASM/height2 and negatively 
correlated with ASM/weight [27]. The study suggested that 
ASM/weight is a more appropriate index than ASM/height2 
for the measurement of sarcopenic obesity [27]. In another 
study, the role of muscle tissue as an internal glucose-regulat-
ing organ was reflected better by ASM/weight than by ASM, 
ASM/height2, muscle strength, or walking speed [28]. Our 
findings are consistent with these results in the unadjusted 
model. Conversely, the Asian Working Group for Sarcopenia 
recommends using height-adjusted skeletal muscle mass in-
stead of weight-adjusted skeletal muscle mass [21]. Consider-
ing previous and current findings together, when evaluating 
sarcopenia or muscle-related conditions of older adults, their 
whole body size should be considered. 
 There are several possible explanations for the association 
between sarcopenia and insulin resistance in the elderly. Sar-
copenia is typically characterized by reductions in the size and 
number of muscle fibers [29]. These reductions are related to a 
combination of decreased anabolism and increased catabo-
lism [30]. Because skeletal muscle is the tissue predominantly 
responsible for insulin-mediated glucose disposal, sarcopenia 
can have a negative impact on insulin sensitivity. A case-con-
trol study presented evidence of the dysfunction of skeletal 
muscle mitochondrial activity along with reduced muscle 
mass, increased adiposity, oxidative stress, and reduced glu-
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cose tolerance in elderly adults [31]. Dysfunction of skeletal 
muscle mitochondrial activity and increased insulin resistance 
can mutually amplify each other with aging [32]. Increasing 
evidence supports the pathological association between sarco-
penia and metabolic syndrome in a bidirectional association. 
Sarcopenia, an age-related loss of muscle mass, may contribute 
to the development of insulin resistance that in turn exacer-
bates the loss of skeletal muscle. Considering all of these find-
ings, sarcopenia and insulin resistance interact with each other 
and aging.
 This study has a few strengths. First, we recruited partici-
pants from a community of a single ethnic background. There-
fore, we could minimize the effects of important confounders 
including ethnicity, residential area, and environmental factors. 
Second, using multiple statistical models, we controlled and 
evaluated the effects of other confounders including sex, age, 
body size, physical health, health behaviors, and mobility func-
tion. Third, we used three forms of muscle values, including 
ASM, ASM/height2 and ASM/weight, for estimating partici-
pants’ muscle conditions.
 Our study also has limitations to be discussed. First, this 
study is limited by its cross-sectional design. The causal rela-
tionship between skeletal muscle mass and insulin resistance 
was not evaluated in this study. Second, the number of partici-
pants was relatively small; thus, we could not conduct further 
analyses according to age group or obesity status. Third, skele-
tal muscle mass was measured via a bioelectrical impedance 
analysis method in this study. Although dual-energy X-ray ab-
sorptiometry is widely used to measure skeletal muscle mass, 
owing to its limited accessibility, bioelectrical impedance anal-
ysis method is increasingly used as alternative [33,34]. Fourth, 
our findings may not be generalizable to other ethnic or age 
groups because the study was conducted among older Korean 
adults recruited from a single rural community. Moreover, the 
study population was a selected group of people who visited 
the public health center and completed physical examinations. 
These factors may limit the generalizability of our study find-
ings. However, in the comparison between people with and 
without body composition analysis, no significant differences 
existed in terms of health behaviors, depression, self-rated 
health, and most common chronic disorders, except for hy-
pertension.
 In conclusion, lower skeletal muscle mass was associated 
with increased insulin resistance in a healthy elderly Korean 
population, and the association was more prominent in men 
than in women. Additionally, when evaluating sarcopenia or 
muscle-related conditions of older adults, their whole body 
size should be considered. 
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